| Serial Number | 79422826 |
| Word Mark | NUCLEOME |
| Filing Date | Thursday, February 13, 2025 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Thursday, July 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Computer software; computer platform software; computer database software; computer software for data analysis and reporting; computer software for the sequencing, annotation, analysis, interpretation and reporting of genome data; computer software for potential patient identification, potential patient stratification and medical diagnosis; computer software for drug discovery and research; computer software for research and medical purposes; computer software for analysis of data relating to pharmaceutical development; computer databases; computer database servers; computer software for database management; computer software for creating searchable databases of information and data. |
| Goods and Services | Reagents and kits for research, industry and diagnostic purposes [not for medical or veterinary use]; reagents and kits for medical research; biological preparations for use in research, industry and science; human cells and isogenic cell lines for research or scientific purposes [not for medical or veterinary use]. |
| Goods and Services | Analysis of data for medical and health purposes; providing information, advice and data relating to genetics and pharmaceuticals for medical and health purposes; pharmaceutical services; medical and health services relating to DNA, genetics and genetic testing; providing a computer database featuring information regarding health; consultancy, advisory and/or information services relating to or connected with the aforementioned services. |
| Goods and Services | Research and development services; scientific research and development services; biotechnology research and development services; pharmaceutical research and development services; drug discovery; pharmaceutical drug development; research and development services in the field of genomics; structural and functional analysis of genomes; research and development services in the field of bioinformatics; research and development services in the field of personalised medicine; research and development services in the field of precision medicine; research and development services in the field of stratified medicine; research and development in the field of drug discovery; research and development in the field of drug target discovery; research and development services in the field of clinical trial design; research and development services in the field of medical diagnostics; research and development of pharmaceuticals and compounds; research and development of pharmaceutical preparations and medicines; research and development of medicines; medical research and development services; research related to genomics, bioinformatics, personalised medicine, precision medicine, drug discovery; design and development of databases; design and development of computer software; design and development of computer databases; database design and development services; computer database design and development services; design and development of computer software for services in the field of pharmaceuticals, clinical trials, personalised medicine and genetics; design and development of computer database for services in the field of pharmaceuticals, clinical trials, personalised medicine and genetics; genome interpretation services; providing computer software and databases as a service for genome sequencing, annotation, interpretation and reporting; providing software and databases as a service for drug discovery and research; providing software and databases as a service for potential patient identification, potential patient stratification or medical diagnosis; providing software and databases as a service for research and medical purposes; information, advisory and consultancy services in relation to all of the aforesaid; cell-line engineering services; gene-editing services; consultancy, advisory and/or information services relating to or connected with the aforementioned services. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 1, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 1, 2025 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 1, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 1, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Nucleome Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, May 1, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, July 21, 2025 | ASSIGNED TO EXAMINER |
| Thursday, July 24, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, July 25, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, May 2, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 2, 2025 | APPLICATION FILING RECEIPT MAILED |